LA ROCHE-POSAY INTRODUCES MELA B SERUM

0
174

La Roche-Posay, Australia’s leading dermatologist-recommended skincare brand, has unveiled its latest innovation in skincare – the Mela B3 Serum. This serum is designed to target hyperpigmentation with unprecedented efficacy, boasting an impressive 85% visible correction of dark spots on all skin tones. The key ingredient, multi-patented Melasyl™, sets this serum apart as a groundbreaking formula that tackles persistent hyperpigmentation issues, including sunspots, age spots, post-acne marks, and even the most stubborn dark spots.

Years of research and extensive screening of over 100,000 molecules led to the development of Melasyl™ by L’Oréal, marking a significant breakthrough in combating hyperpigmentation. This unique ingredient acts proactively, targeting dark spots before they become visible. Combined with Niacinamide, which helps to visibly fade existing discoloration and soothe the skin, the Mela B3 Serum offers a comprehensive approach to skin brightening.

The formula also includes LHA to increase cell turnover, Hyaluronic Acid for hydration and skin barrier protection, and Pro-Retinol to enhance skin tone and radiance. This intricate blend of ingredients ensures fast and effective correction of hyperpigmentation, making Mela B3 Serum a standout solution in the skincare market.

Rachel McAdam, Head of Medical Relations at L’Oréal Dermatological Beauty, explains the significance of this formulation, stating, “For the first time, La Roche-Posay has developed a serum that targets pigmentation from multiple angles, resulting in a synergistic impact.”

She emphasizes the widespread impact of pigmentation disorders, stating, “Pigmentation disorders affect so many of us.” Highlighting the importance of prevention she recommends the combination of Mela B3 Serum with a broad-spectrum sunscreen like La Roche-Posay’s Anthelios Invisible Fluid Facial Sunscreen SPF50+. McAdam notes, “It’s important to make sure you combine the use with a broad-spectrum sunscreen such as La Roche-Posay’s Anthelios Invisible Fluid Facial Sunscreen SPF50+ as UV damage can be a cause for hyperpigmentation.” This holistic approach to skincare underscores the brand’s commitment to addressing not just existing issues but also preventing future concerns.

A recent epidemiology study conducted by La Roche-Posay involving 48,000 participants across 34 countries revealed a significant demand for hyperpigmentation solutions. Dr. Michelle Rodrigues, Dermatologist, Founder, and Director of Chroma Dermatology and La Roche-Posay partner, emphasizes the diverse nature of hyperpigmentation, stating, “Hyperpigmentation comes in many shapes and forms, and there is a need for a new, safe, and effective over-the-counter molecule that targets various forms of hyperpigmentation.”

The Mela B3 Serum is now available for purchase, offering a daily solution to visibly reduce hyperpigmentation and skin discoloration. Priced at $79.95 for a 30ml bottle, this serum promises long-lasting results while respecting the natural tone of all skin types. For optimal use, apply 3-4 drops to cleansed skin morning and evening, followed by a broad-spectrum SPF 50+ sunscreen during the day.

Experience the groundbreaking power of La Roche-Posay’s Mela B3 Serum, now available at www.laroche-posay.com.au

Adore Beauty, Priceline and Chemist Warehouse

LEAVE A REPLY

Please enter your comment!
Please enter your name here